99012197 - SYTHEIA

Information

• Trademark
• 99012197

• Source

• Serial Number

  99012197

• International Classifications

  • 5 - Pharmaceutical and veterinary preparations

• Filing Date

  January 18, 2025
  4 months ago

• Transaction Date

  January 18, 2025
  4 months ago

• Status Date

  January 18, 2025
  4 months ago

• Location Date

  January 18, 2025
  4 months ago

• Status Code

  630

• Attorney Docket Number

  OCU-TM000900

  Attorney Name

  Don Cha

• Owners

  • Ocugen, Inc.

Case File Statements

• GS0051: Gene therapy products, namely, genetically engineered tissues for transplant purposes; Gene therapy products, namely, recombinant adeno-associated virus (rAAV) vector for treating ocular diseases; Gene therapy products, namely, rAAV vector for treating Retinitis Pigmentosa; Gene therapy products, namely, recombinant nucleic acid for treating ocular diseases; Gene therapy products, namely, recombinant nucleic acid for treating Retinitis Pigmentosa; Gene therapy products, namely, recombinant DNA for treating ocular diseases; Gene therapy products, namely, recombinant DNA for treating Retinitis Pigmentosa; Gene therapy products, namely, rAAV for treating ocular diseases such as Leber congenital amaurosis (LCA), retinitis pigmentosa, enhance S-cone syndrome, Goldmann Favre syndrome, rod-cone dystrophy Bardet-Biedl Syndrome, Achromatopsia, Best Disease (vitelliform macular degeneration), Bardet-Biedl Syndrome, Choroideremia, Macular Degeneration, Stargardt Disease, X-Linked Retinoschisis (XLRS), X-Linked Retinitis Pigmentosa (XLRP), Usher Syndrome, cone-rod dystrophy, Dry-Age related macular degeneration, and wet-Age related macular degeneration

Case File Event Statements

• 1/18/2025 - 4 months ago

  1 - NEW APPLICATION ENTERED Type: NWAP

• 1/18/2025 - 4 months ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 1/18/2025 - 4 months ago

  3 - APPLICATION FILING RECEIPT MAILED Type: MAFR